Pharvaris NVPHVS
13F holders, Q2 2024 (June 30)At the end of Q2 2024, 36 institutions reported holding Pharvaris NV (PHVS) in their 13F filings, up 1 from Q1 2024. 5 opened new positions and 4 sold out. The largest holders were General Atlantic, L.P. ($141.6M), FMR LLC ($97.9M) and Foresite Capital Management IV, LLC ($80.7M). 3 famous investors held it, including Andreas Halvorsen (0.3% of Viking Global Investors's portfolio), Israel Englander (0.0% of Millennium Management's portfolio) and Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Pharvaris NV
- CUSIP
- N69605108
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 5 | $1.1M |
| Exits | 4 | $1.5M |
All 13F filers, Q1 2024 → Q2 2024: 1,381,624 shares bought and 798,601 shares sold, net +583,023 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 36 holders
| General Atlantic, L.P. | 4.45% | No change | 7,531,252 | $141.6M |
| FMR LLC | 0.01% | Add +0.2% | 5,205,656 | $97.9M |
| Foresite Capital Management IV, LLC | 54.23% | Add +6.3% | 4,293,854 | $80.7M |
| venBio Partners LLC | 34.83% | No change | 4,289,304 | $80.6M |
| Viking Global Investors | 0.26% | No change | 3,653,310 | $68.7M |
| Venrock Adviser, LLC | 4.07% | No change | 3,395,606 | $63.8M |
| Bain Capital Life Sciences Investors, LLC | 6.82% | No change | 3,303,381 | $62.1M |
| Commodore Capital LP | 2.32% | Add +4.9% | 1,810,175 | $34.0M |
| Novo Holdings A/S | 1.75% | Add +47.7% | 1,725,000 | $32.4M |
| Cormorant Asset Management, LP | 1.60% | Reduce -14.3% | 1,466,460 | $27.6M |
| Deerfield Management Company, L.P. | 0.51% | Add +31.6% | 1,397,279 | $26.3M |
| EcoR1 Capital, LLC | 0.52% | No change | 900,000 | $16.9M |
| 5AM Venture Management, LLC | 3.35% | No change | 797,600 | $15.0M |
| Rock Springs Capital Management LP | 0.43% | Add +0.5% | 756,931 | $14.2M |
| Sofinnova Investments, Inc. | 0.71% | Add +2.9% | 601,534 | $11.3M |
| T. Rowe Price Associates Inc. | 0.00% | Reduce -22.8% | 585,271 | $11.0M |
| Sphera Funds Management LTD. | 1.24% | Add +2.6% | 403,265 | $7.6M |
| Soleus Capital Management, L.P. | 0.66% | Reduce -0.6% | 399,430 | $7.5M |
| TD Asset Management Inc | 0.00% | Reduce -23.8% | 85,816 | $1.6M |
| Goldman Sachs Group Inc. | 0.00% | Add +97.5% | 61,470 | $1.2M |
| Manufacturers Life Insurance Company, The | 0.00% | No change | 55,078 | $1.0M |
| Marshall Wace, LLP | 0.00% | Reduce -12.0% | 51,168 | $962K |
| Walleye Capital LLC | 0.01% | Reduce -49.8% | 48,768 | $917K |
| Millennium Management | 0.00% | Add +89.7% | 38,945 | $732K |
| Atle Fund Management AB | 0.39% | New | 34,328 | $645K |
| Geode Capital Management, LLC | 0.00% | No change | 31,224 | $587K |
| Morgan Stanley | 0.00% | Reduce -19.8% | 23,296 | $438K |
| HighVista Strategies LLC | 0.12% | No change | 16,750 | $315K |
| Y-Intercept (Hong Kong) Ltd | 0.02% | New | 15,883 | $299K |
| Citadel Advisors | 0.00% | Reduce -93.9% | 14,472 | $272K |
| Bank of America Corp. | 0.00% | Reduce -21.6% | 6,121 | $115K |
| Virtus Advisers, LLC | 0.05% | New | 5,001 | $94K |
| BlackRock Inc. | 0.00% | No change | 2,268 | $43K |
| ADAR1 Capital Management, LLC | 0.01% | No change | 2,000 | $38K |
| Wells Fargo & Company | 0.00% | New | 700 | $13K |
| UBS Group AG | 0.00% | New | 167 | $3K |
"% of holder's portfolio" is PHVS's weight in each manager's 13F, not the share of Pharvaris NV the manager owns.